Copyright © 2013 Quintiles
The Collaboration
Mandate
July 2013
Adam Istas
Thought Leadership Director - Quintiles
2
The Collaboration Mandate
• Objectives
> Since 2010 Quintiles has commissioned
independent research to develop and publi...
3
The Collaboration Mandate
Key Findings
Payers, providers and
biopharma agree that
they need to be better
aligned with ot...
4
The Collaboration Mandate
Key Findings
All three groups rated
improved health
outcomes and
innovation among the
greatest...
5
The Collaboration Mandate
Key Findings
More than 70% of all
stakeholders believe
transparency around
data sources and
in...
6
The Collaboration Mandate
Key Findings
At least three out of
four survey participants
believe it is very
important or ex...
7
Implications / Recommendations
The report outlines recommendations for biopharma to improve their
collaboration to benef...
8
Contact Information
Mari Mansfield, Corporate Communications
mari.mansfield@quintiles.com
O: +1 919 998 2639
M: +1 919 2...
Upcoming SlideShare
Loading in …5
×

The Collaboration Mandate - Survey Overview

1,463 views

Published on

Published in: Economy & Finance, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,463
On SlideShare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
10
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

The Collaboration Mandate - Survey Overview

  1. Copyright © 2013 Quintiles The Collaboration Mandate July 2013 Adam Istas Thought Leadership Director - Quintiles
  2. 2 The Collaboration Mandate • Objectives > Since 2010 Quintiles has commissioned independent research to develop and publish The New Health Report. • Methodology > 53 Provider executives - Representing integrated healthcare systems and academic medical centers - 100% from the US > 143 Payer executives - 68 from managed care organizations in the US - 75 from government payer organizations in Europe » (France, Germany, Italy, Spain, United Kingdom) > 102 Biopharmaceutical executives - Vice-president level and above - At least 25% from outside the U.S. Objectives & Methodology 102 68 75 53 Biopharma US Payers EU Payers Providers
  3. 3 The Collaboration Mandate Key Findings Payers, providers and biopharma agree that they need to be better aligned with other stakeholders in the healthcare industry, yet they have struggled to achieve this goal. Only 16-19% of survey respondents said they were mostly aligned with other stakeholders, while one-fourth said they are not very or not at all aligned.
  4. 4 The Collaboration Mandate Key Findings All three groups rated improved health outcomes and innovation among the greatest benefits of cross-stakeholder initiatives. Payers are also interested in reducing the cost of care, providers seek improved care experiences and biopharma wants to accelerate the rate at which new therapies get to market.
  5. 5 The Collaboration Mandate Key Findings More than 70% of all stakeholders believe transparency around data sources and information-sharing across stakeholders is very important or critically important to the success of an interoperable healthcare system. Their biggest obstacles to adopting a systems- oriented approach are lack of trust, poor financial incentives and varying definitions of value.
  6. 6 The Collaboration Mandate Key Findings At least three out of four survey participants believe it is very important or extremely important for data sources collected by different stakeholders to be linked together to better inform decisions. However, more than half feel they have neither the tools nor the expertise to optimize use of these data sets.
  7. 7 Implications / Recommendations The report outlines recommendations for biopharma to improve their collaboration to benefit business and improve patient outcomes. • Diversify partnerships to drive innovation. Seek opportunities to partner with stakeholders from across the healthcare continuum. Ideally these opportunities will stretch comfort zones beyond the traditional regulatory partnerships, with the promise of innovation in exchange for transparency and a willingness to work collaboratively for mutual benefit. • Build the roadmap together. Define success and then work in concert with partners to build the roadmap to get there. When collaboration has a destination, every individual heads in the same direction. • Foster—and use—feedback. Regularly review results through formal check points and feedback channels with a focus on how to continually optimize design based on system feedback. Ensure stakeholders stay connected to the team and foster a culture of trust by communicating results and feedback regularly across the stakeholder community.
  8. 8 Contact Information Mari Mansfield, Corporate Communications mari.mansfield@quintiles.com O: +1 919 998 2639 M: +1 919 259 3298 Laura Wilson, Corporate Communications - Europe laura.e.wilson@quintiles.com O: +44 118 450 8392 M: +44 7854 173 106 > http://www.quintiles.com/collaborationmandate For additional information about The Collaboration Mandate

×